Amitriptyline for Major Depressive Disorder: Dosage and Usage Guidelines
For major depressive disorder, amitriptyline should be initiated at 75 mg daily in divided doses for outpatients, which can be increased to a maximum of 150 mg per day, with increases preferably made in the late afternoon and/or bedtime doses. 1
Initial Dosing and Titration
Standard outpatient dosing:
- Start with 75 mg of amitriptyline daily in divided doses
- Can be increased to a total of 150 mg per day if necessary
- Alternative method: Begin with 50-100 mg at bedtime, increasing by 25-50 mg as needed to a total of 150 mg daily 1
Special populations:
Maintenance Therapy
- Usual maintenance dosage: 50-100 mg per day (in some patients, 40 mg daily is sufficient)
- For maintenance, the total daily dosage may be given as a single dose, preferably at bedtime
- Continue maintenance therapy for 4-9 months after satisfactory improvement to reduce relapse risk 2, 1
- For patients with 2 or more episodes of depression, longer maintenance therapy (years to lifelong) may be beneficial 2
Monitoring and Response Assessment
- Begin assessing therapeutic response within 1-2 weeks of starting treatment 2
- An adequate therapeutic effect may take up to 30 days to develop 1
- Monitor for adverse effects, particularly:
- Anticholinergic effects (dry mouth, constipation, urinary retention)
- Sedation and drowsiness
- Cardiovascular effects (obtain ECG for patients over 40)
- Weight gain
Clinical Considerations
- Amitriptyline is a tricyclic antidepressant with significant sedative properties, making it particularly useful when administered at bedtime
- The American College of Physicians recommends that clinicians modify treatment if there is no adequate response within 6-8 weeks 2
- Be aware that sedative effects may appear before antidepressant effects 1
Cautions and Contraindications
- Tricyclic antidepressants can be lethal in overdose, so prescribe appropriate quantities
- Use with caution in patients with cardiac disease due to risk of cardiotoxicity
- When discontinuing, taper over 10-14 days to avoid discontinuation syndrome
- Not recommended for children under 12 years of age 1
Comparative Efficacy
- The American College of Physicians notes that second-generation antidepressants (SSRIs, SNRIs) have similar efficacy to tricyclics like amitriptyline but generally have better tolerability profiles 2
- Studies comparing amitriptyline to fluoxetine found comparable efficacy but different side effect profiles, with amitriptyline causing more anticholinergic effects and weight gain 3, 4
Remember that while amitriptyline is effective for major depressive disorder, its side effect profile (particularly anticholinergic effects, sedation, and cardiovascular concerns) may make second-generation antidepressants preferable for many patients unless specific indications for amitriptyline exist.